FDA Investigator Gilbert Valdez, RS
Gilbert Valdez, RS has conducted inspections on 21 sites in 1 countries as of 10 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
21
Last Inspection Date:
10 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gilbert Valdez, RS:
Ademola O Daramola,
Akbar J Zaidi,
Blondell W Johnson,
Camerson E Moore,
Chloe Burnley,
Christopher D Rush,
Daniel S Fam,
Danny D Horner,
Darla J Christopher,
Dr. Jason R Caballero,
Elisa M Fleming,
Ellen J Tave,
Elmina E Akwo,
Emilio O Escobar,
Iris C Macinnes,
J Elkins,
Janete F Guardia,
Jd Young,
Jeffrey R Wooley,
Jessica Fierros, RS,
Jocelyn C Turner,
Johann M Fitch,
Kristin N Longfellow,
Lauren E Skokan,
Luis E Gonzalez,
Marcia G Evans,
Pauline N Logan,
Ronda Rloyd Jones,
Roy Baby,
Scott J Trsenjak,
Sha'tina R Alridge,
Shafiq S Ahadi,
Stephen D Brown,
Tricia S Martinez,
Tuan A Nguyen,
Vickie L Anderson,
Yvette E Guillermo
Gilbert Valdez, RS's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more